Income statement, balance sheet and cash flow statement for the last 8 fiscal years, taken from the XBRL data Hestia Insight Inc. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2018
FY2020
FY2020
FY2021
FY2022
FY2023
FY2023
FY2025
Revenue
0.12
0.14
0.03
0.02
0.11
1.25
0.01
Cost of revenue
0
Gross profit
0.14
0.03
0.02
0.11
Selling, general and administrative
0.29
0.15
0.25
0.36
0.42
0.4
0.31
Operating expenses
0.29
0.15
0.25
0.36
0.42
0.4
0.31
Operating income
-0.17
-0.01
-0.22
-0.35
-0.3
0.85
-0.3
Interest expense
0
0
0
0.01
Interest income
0
0
0
Other non-operating income
-0.05
11.5
-9.55
-1.37
-0.19
-0.12
-0.73
Pre-tax income
-0.22
11.5
-9.77
-1.71
-0.5
0.73
-1.04
Income tax
0
0
0
0
0
-0.09
Net income
-0.09
-0.22
11.5
-9.77
-1.71
-0.5
0.64
-0.94
EBITDA
-0.34
-0.29
0.86
-0.3
EPS, basic
0.00
0.41
-0.35
-0.06
-0.02
-0.03
0.02
EPS, diluted
0.00
0.41
-0.35
-0.06
-0.02
-0.03
0.02
Shares, basic (weighted)
74.2
28.4
28
27.9
27.9
Shares, diluted (weighted)
10,838
28.4
28
27.9
27.9
Balance sheet
FY2018
FY2020
FY2020
FY2021
FY2022
FY2023
FY2023
FY2025
Cash and equivalents
0.12
0.56
0.6
0.52
0.25
0.09
0.04
0.03
Receivables
0.01
Other current assets
0
0
0
Total current assets
0.64
12.1
2.33
0.56
0.17
1.12
0.4
Property, plant and equipment
0.01
0.11
0.03
0.02
Lease right-of-use assets
0
0.02
0.01
0.01
Total assets
0.64
12.1
2.35
0.71
0.19
1.15
0.4
Accounts payable
0
0.02
0.02
0.01
0.02
0.03
0.08
Accrued liabilities
0
Total current liabilities
0.11
0.02
0.02
0.03
0.02
0.21
0.28
Lease liabilities
0
0.01
0.01
Total liabilities
0.11
0.04
0.03
0.03
0.02
0.21
0.28
Paid-in capital
0.8
0.81
0.83
0.9
0.9
1.02
1.14
Retained earnings
-0.3
11.2
1.46
-0.26
-0.76
-0.11
-1.06
Treasury stock
-0
-0
-0.01
Shareholders' equity
0.11
0.53
12.1
2.32
0.68
0.18
0.94
0.12
Total equity
0.11
0.53
12.1
2.32
0.68
0.18
0.94
0.12
Total liabilities and equity
0.64
12.1
2.35
0.71
0.19
1.15
0.4
Shares outstanding
27.9
27.9
27.9
27.9
27.9
27.9
27.9
Cash flow statement
FY2018
FY2020
FY2020
FY2021
FY2022
FY2023
FY2023
FY2025
Net income
-0.09
-0.22
11.5
-9.77
-1.71
-0.5
0.64
-0.94
Depreciation and amortization
0.01
0.01
0
0
Stock-based compensation
0.12
0.12
Deferred income tax
-0.09
Change in receivables
0
0
-0
0.02
Change in payables
0.01
0.01
-0
-0.01
0.01
0.02
0.05
Cash from operations
-0.02
-0.01
-0.21
-0.28
-0.28
-0.17
-0.13
Cash from investing
-0.08
0.15
0.14
-0.02
0.12
0.04
0.01
Stock issued
0.6
0
0.03
0.08
0.1
Share buybacks
-0.16
0
Cash from financing
0.54
-0.1
-0
0.03
0.08
0.11
Net change in cash
0.44
0.04
-0.07
-0.27
-0.16
-0.05
-0.01
Key metrics
Worked out from the statements above. Latest values use the trailing twelve months to May 31, 2026; growth uses fiscal years. Valuation uses the share price of $0.03 on September 25, 2026.
Profitability
Metric
Value
How it is calculated
Operating margin
-2,635.0%
Operating income / revenue.
EBITDA margin
-2,635.0%
EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin
-3,623.0%
Pre-tax income / revenue.
Net margin
-3,240.0%
Net income / revenue.
Operating cash flow margin
-577.1%
Cash from operations / revenue.
Return on assets (ROA)
-164.2%
Net income / average total assets.
SG&A / revenue
2,735.0%
Selling, general and administrative expense / revenue.
Stock-based pay / revenue
0.0%
Stock-based compensation (from the cash flow statement) / revenue.
D&A / revenue
0.5%
Depreciation and amortization / revenue.
Growth
Metric
Value
How it is calculated
Revenue growth, 1y
-99.4%
Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y
-18.9%
Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y
-43.8%
Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y
-135.8%
Operating income vs the same period a year earlier. Only from a positive base.
EBITDA growth, 1y
-135.5%
EBITDA vs the same period a year earlier. Only from a positive base.
Net income growth, 1y
-246.9%
Net income vs the same period a year earlier. Only from a positive base.
EPS CAGR, 5y
-45.3%
Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y
-87.6%
Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y
-44.4%
Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y
-60.4%
Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y
-65.5%
Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y
-17.8%
Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y
-49.6%
Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y
0.0%
Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y
-0.3%
Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
0.57x
Current assets / current liabilities.
Quick ratio
0.02x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
0.02x
(Cash + short-term investments) / current liabilities.
Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share
$0.00
Revenue / diluted weighted shares.
Operating cash flow per share
-$0.00
Cash from operations / diluted weighted shares.
Book value per share
-$0.01
Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Market cap + total debt - cash - short-term investments.
P/S
35.5x
Market cap / revenue.
EV/Sales
34.7x
Enterprise value / revenue.
Earnings yield
-91.3%
Net income / market cap (the inverse of P/E).
What was Hestia Insight Inc.'s revenue in fiscal 2025?
Hestia Insight Inc. reported revenue of $8.0K for fiscal 2025, 99.4% lower than the year before.
Was Hestia Insight Inc. profitable in fiscal 2025?
No. It reported a net loss of $943.4K.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.